The GIST of it: Case reports of a gastrointestinal stromal tumour and a leiomyoma of the anorectum

ANZ Journal of Surgery

Volumn 73, Issue 3, 2003, Pages 167-169

  Huilgol, Ravi L ^a   Young, Christopher J ^a   Solomon, Michael J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Gastrointestinal neoplasms; Leiomyoma; Smooth muscle tumours

Indexed keywords

ADULT; ANORECTAL MALFORMATION; ARTICLE; CASE REPORT; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; LEIOMYOMA; MESENCHYMOMA; STEM CELL; STROMA CELL; TUMOR GROWTH;

FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LEIOMYOMA; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASMS, MULTIPLE PRIMARY; RECTAL NEOPLASMS; STROMAL CELLS;

EID: 0037368474     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2003.02643.x     Document Type: Article

References (15)

1. Hirota S, Isozaki K, Moriyami Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumours. Science 1998; 279: 577-80.
2. Miettinen M, Sarlomo-Rikala M, Lasoto J. Gastrointestinal stromal tumours: Recent advances in understanding of their biology. Hum. Pathol. 1999; 30: 1213-20.
3. Meittinen M, Virolainen M, Rikala M. Gastrointestinal stromal tumours - value of CD 34 antigen in their identification and separation from true leiomyomas and schwannomas. Am. J. Surg. Pathol. 1995; 19: 207-16.
4. Van de Rijn M, Hendrickson M, Rouse R. CD 34 expression by gastrointestinal tract stromal tumours. Hum. Pathol. 1994; 25: 766-71.
5. Druker BJ, Talpas M, Testa DJ et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukaemia. N. Engl. J. Med. 2001; 344: 1031-7.
6. Joensuu H, Roberts P, Sarlomo-Rikala M et al. Brief report: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N. Engl. J. Meal. 2001; 344: 1052-6.
7. Olangwen I, Ariza A, Navas-Palacios J. Gastrointestinal autonomic nerve tumour: further observations regarding and ultrastructural and immunohistochemical analysis of six cases. Hum. Pathol. 1996; 27: 1311-8.
8. Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 1996; 111: 492-515.
9. Ranjani B, Smith T, Reith J, Goldblum J. Retroperitoneal leiomyosarcomas unassociated with the gastrointestinal tract. A clinicopathologic analysis of 17 cases. Mod. Pathol. 1999; 12: 21-8.
10. Clary BDE, Matteo R, Lewis J. Gastrointestinal stromal tumours and leiomyosarcomas of the abdomen and retroperitoneum: a clinical comparison. Ann. Surg. Oncol. 2001; 8: 290-9.
11. Skandalakis J. Smooth muscle tumours of the gastrointestinal tract: Introduction. World J. Surg. 2000; 24: 389-90.
12. Chou F, Eng H-L, Sheen-Chen S-M. Smooth muscle tumours of the gastrointestinal tract: Analysis of prognostic factors. Surgery 1996; 119: 171-7.
13. Lasoto J, Jasinski M, Sarlomo-Rikala M, Miettenen M. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumours and do not occur in leiomyomas or leiomyosarcomas. Am. J. Pathol. 1999; 154: 53-60.
14. Miettinen M, Sarlomo-Rikala M, Sobin L, Lasota J. Gastrointestinal stromal tumours and leiomyosarcomas in the colon, a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am. J. Surg. Pathol. 2000; 24: 1339-52.
15. Spiliotis J, Scopa CD, Kyriakopolou D et al. Smooth muscle tumours of the gastrointestinal tract: a 10-year experience. Eur. J. Surg. Oncol 1992; 18: 580-4.